viernes, 5 de abril de 2019

Fining one 'predatory' publisher won't end bad science in journals - STAT

Fining one 'predatory' publisher won't end bad science in journals - STAT

The Readout

Damian Garde

More reads

  • Scientists take aim at disease-causing RNAs using small-molecule drugs. (The Scientist)
  • FDA's Pazdur encourages Chinese companies to bring low-cost PD-1 drugs to U.S. market. (BioCentury)
  • Fining one ‘predatory’ publisher won’t fix the problem of bad science in journals. (STAT)

No hay comentarios: